Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
– Study Met Primary Endpoint of Reduction of Time to Recovery– Additional Analyses Ongoing to Understand Other Clinical Outcome Data– […]